Regenerative medicine: Antagonic-stress® therapy in distress and aging. I. Preclinical synthesis - 2003

Annals of the New York Academy of Sciences

Volumn 1019, Issue , 2004, Pages 396-400

  Riga, D ^a   Riga, S ^a   Schneider, F ^b  

^a Alexandru Obregia Psychiatric Hospital Bucharest   (Romania)

^b VASILE GOLDIS WESTERN UNIVERSITY OF ARAD   (Romania)

Author keywords

Antistress and antiaging therapy; Preclinical studies; Regenerative medicine; Synthesis

Indexed keywords

ANTAGONIC STRESS; DIPOTASSIUM HYDROGEN PHOSPHATE; FATTY ACID; FRUCTOSE; LITHIUM CARBONATE; MAGNESIUM ASPARTATE; MAGNESIUM OXIDE; MECLOFENOXATE; METHIONINE; NICOTINIC ACID; NOOTROPIC AGENT; OROTIC ACID; POTASSIUM IODIDE; PROTEIN; PYRIDOXINE; RNA; SUPEROXIDE DISMUTASE; THIAMINE; UNCLASSIFIED DRUG; ZINC SULFATE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; BIOSYNTHESIS; BRAIN; BRAIN CORTEX; CELL ISOLATION; CONFERENCE PAPER; CONTROLLED STUDY; DISSOLUTION; DRUG ABSORPTION; GLIA CELL; HEART; HOMEOSTASIS; LIVER REGENERATION; MENTAL STRESS; MITOCHONDRION; MORTALITY; MOUSE; NERVE CELL; NISSL SUBSTANCE; NONHUMAN; RAT; REGENERATION; RIBOSOME; ROUGH ENDOPLASMIC RETICULUM; SENESCENCE; SOLUBILITY; STOMACH ULCER;

ANIMALIA;

EID: 3242681527     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1297.071     Document Type: Conference Paper

References (10)

1. RIGA, D. & S. RIGA. 1998-2004. Twenty-five patents worldwide of the Antagonic-Stress® drug: AU Pat. (1998), KR Pat. (1999), EUR Pat. (1999) for 16 Eur. States, RU Pat. (2000), US Pat. (2001), CN Pat. (2001), RO Pat. (2001), CA Pat. (2002), JP Pat. (2003), and BR Pat. (2004).
2. DE GREY, A.D.N.J. et al. 2002. Bioremediation meets biomedicine: therapeutic translation of microbial catabolism to the lysosome. Trends Biotechnol. 20: 452-455.
3. RIGA, S. & D. RIGA. 1995. An antistress and antiaging neurometabolic therapy. Accelerated lipofuscinolysis and stimulated anabolic regeneration by the Antagonic-Stress synergistic formula. Ann. N.Y. Acad. Sci. 771: 535-550.
4. RIGA, D. & S. RIGA. 1998. Anti-stress and anti-aging neurometabolic antioxidative therapy. I. Preclinical synthesis. 2nd World Congress Stress. Melbourne, Australia.
5. RIGA, S. & D. RIGA. 1994. Antagonic-Stress: a therapeutic composition for deceleration of aging. I. Brain lipofuscinolytic activity demonstrated by light and fluorescence microscopy. Arch. Gerontol. Geriatr. 19(Suppl. 4): 217-226.
6. RIGA, D. & S. RIGA. 1994. Antagonic-Stress: a therapeutic composition for deceleration of aging. II. Brain lipofuscinolytic activity demonstrated by electron microscopy. Arch. Gerontol. Geriatr. 19(Suppl. 4): 227-234.
7. RIGA, D. & S. RIGA. 1995. Brain lipofuscinolysis and ceroidolysis. In Lipofuscin and Ceroid Pigments. State of the Art 1995. K. Kitani, G.O. Ivy & H. Shimasaki, Eds.: 271-280. Karger. Basel, Switzerland.
8. RIGA, D. & S. RIGA. 1998. Correlations between lipofuscin accumulation and aging neuropathology. Ann. N.Y. Acad. Sci. 854: 495.
9. RIGA, D. & S. RIGA. 2000. Stress, oxidative stress, aging and neuro-psychiatric pathology. In Textbook of Mental Health. Vol. 1. D. Prelipceanu, R. Mihailescu & R. Teodorescu, Eds.: 211-225. Encyclopaedic Press. Bucharest, Romania.
10. RIGA, S., D. RIGA & F. SCHNEIDER. 2003. Prolongevity medicine: Antagonic-Stress® drug in stress, aging, and related diseases. II. Clinical review. Biogerontology 4(Suppl. 1): 82.